Cibus, Inc. CBUS
Regular-session close
After hours · Nov 16, 4:00 PM ET
- YTD
- -31.03%
- 1 year
- -1.64%
- Market cap
- 91.97M
- Revenue (ttm)
- 4.15M
- EPS (ttm)
- -1.46
- Shares out
- 26.46M
- Forward P/E
- -1.09
- YTD return
- -31.03%
- 1-year return
- -1.64%
- 50-day average
- 4.14
- 200-day average
- 9.75
- Volume
- 102.11K
- Avg volume
- 106.25K
- Open
- 1.12
- Previous close
- 1.13
- Day's range
- 1.07 – 1.21
- 52-week range
- 1.02 – 4.19
- Beta
- 1.79
- Analysts
- Buy
- Price target
- 18.13 (+1410.4%)
5D -0.16 (-13.33%)
Key statistics
- Enterprise value
- 90.65M
- Price / sales
- 20.22
- Price / book
- 0.69
- Revenue growth
- 250.90%
- Free cash flow
- -48.61M
- Total cash
- 28.80M
- Total debt
- 36.74M
- Return on equity
- -149.74%
- Short % of float
- 12.40%
Fundamental scorecard
4 of 25 checks passed on CBUS’s reported financials
4of 25 checks passed
- Value 1 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 0 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -0.90 | 0.06 | +0.96 | +106.67% |
| Aug 8, 2024 | Jun 1, 2024 | -0.81 | -1.14 | -0.33 | -40.74% |
| May 9, 2024 | Mar 1, 2024 | -1.01 | -1.12 | -0.11 | -10.89% |
| Mar 21, 2024 | Dec 1, 2023 | -1.12 | -1.16 | -0.04 | -3.57% |
| Nov 9, 2023 | Sep 1, 2023 | -1.18 | -1.59 | -0.41 | -34.75% |
| Aug 9, 2023 | Jun 1, 2023 | -0.30 | -3.05 | -2.75 | -916.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 11, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 22, 2024 | Canaccord Genuity | main | Buy | Buy |
| Sep 24, 2024 | Alliance Global Partners | main | Buy | Buy |
| Sep 19, 2024 | Canaccord Genuity | main | Buy | Buy |
| Aug 12, 2024 | Canaccord Genuity | main | Buy | Buy |
| Jul 29, 2024 | Alliance Global Partners | init | — | Buy |
About Cibus, Inc.
Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cibus.com
News
Cibus, Inc. (CBUS) Q3 2026 Earnings Call Transcript
What Cibus (CBUS) Said on Its Q3 Earnings Call
Cibus (CBUS) Reports Q3 Loss, Lags Revenue Estimates Cibus Q3 EPS $(0.29) Misses $(0.27) Estimate, Sales $800.000K Miss $1.283M Estimate
Cibus Reports Third Quarter Financial Results and Provides Business Update
Your note
Sign in to keep a note on CBUS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROOS CORNELIS | Chief Financial Officer | Sale | Nov 11, 2024 | 74,197 |
| CARR MICHAEL A | Chief Executive Officer | Stock Award(Grant) | May 30, 2023 | 33,174 |
| FREY TRAVIS | Chief Technology Officer | Stock Award(Grant) | May 30, 2023 | 19,060 |
| FRIMERMAN DEBRA H. | General Counsel | Stock Award(Grant) | May 30, 2023 | 18,772 |
| GOCAL GREG FRANCIS WILLIAM | Officer | Sale | Jul 14, 2024 | 314,844 |
| KING WADE HAMPTON M.D. | Chief Financial Officer | Stock Award(Grant) | May 30, 2023 | 212,100 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 14.79% | 3,913,279 | 11.11M | Sep 29, 2024 |
| Vantage Consulting Group, Inc | 4.32% | 1,143,949 | 3.25M | Sep 29, 2024 |
| Blackrock Inc. | 4.04% | 1,068,342 | 3.03M | Sep 29, 2024 |
| Vanguard Group Inc | 3.17% | 838,952 | 2.38M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.38% | 364,923 | 1.04M | Sep 29, 2024 |
| State Street Corporation | 1.16% | 307,262 | 872.62K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 4.61% | 1,218,674 | 3.46M | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.76% | 465,386 | 1.32M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.45% | 382,284 | 1.09M | Oct 30, 2024 |
| Fidelity Growth Company K6 Fund | 1.41% | 373,153 | 1.06M | Oct 30, 2024 |
| Fidelity Series Growth Company Fund | 1.26% | 332,232 | 943.54K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.00% | 264,388 | 750.86K | Sep 29, 2024 |
